If you prefer the reading experience ofMedium you can follow us there as well.
Will telemedicine be one of the emerging drivers of product development in 2021? The short answer is no, because it’s already arrived. As far back as 2019, consumers were excited about telemedicine — an American Well survey found that 66% of respondents were open to using it. This was before the pandemic.
Now, the AMA’s VP of digital innovation estimates that up to 90% of physicians are using telemedicine in some form. McKinsey calls it a “quarter-trillion-dollar post-COVID reality”, citing a 76% interest level among consumers. This means that healthcare technology companies are facing a huge opportunity — and it’s one that’s going to require rapid, pinpoint adjustments in product development to keep up with competition and customer demands.
During the pandemic, telehealth was critical to slowing the spread of COVID-19. Now, innovative companies will need to take a close look at emerging and multifaceted factors to guide their product roadmaps. This will support a necessary refresh of product strategy in a way that both fosters agility and keeps you prepared for the future of telehealth in the far-term.
Be sure to check out our white paper for more information.
Want to learn more about how we’ve helped our clients enrich their product roadmap through telehealth solutions? Start here.